查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1649474

週边血管介入市场：预测（2025-2030）

Peripheral Vascular Intervention Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计週边血管介入市场规模将以 5.74% 的复合年增长率成长，从 2025 年的 137.65 亿美元增至 2030 年的 181.98 亿美元。

週边血管介入治疗（PVI）是一种微创手术，利用灵活的仪器进入心臟外的血管。这些手术可以打通阻塞的血管、清除血栓并控制高血压。 PVI 是一种先进的方法，可最大限度地减少大切口的需要，从而缩短恢復时间、减少疼痛、降低併发症风险并缩短住院时间。介入性心臟科医师利用这些尖端治疗方法来改善患者的治疗效果。週边血管介入市场正在扩大，主要原因是周边动脉疾病（PAD）盛行率上升和技术进步。人们对微创手术的偏好日益增长、人口老化以及医疗保健支出的增加进一步推动了这一增长。週边动脉疾病 (PAD) 限制了手脚的血液流动，并且由于糖尿病、肥胖和吸烟等因素而更加常见。药物释放型支架、动脉粥状硬化斑块切除术状硬化切除装置和栓塞颗粒等创新设备正在改善性能和患者的治疗效果。此外，老年人口的增加和医疗支出的增加也直接导致了这些治疗的需求。

週边血管介入市场驱动因素：

  • 周边动脉疾病（PAD）盛行率不断上升：PAD 发病率不断上升是推动週边血管介入市场成长的关键因素。当供应血液到四肢的动脉变窄或被斑块阻塞时，就会发生週边动脉疾病 (PAD)，引发腿部疼痛和创伤治疗不良等症状。由于不健康的生活方式，週边动脉疾病 (PAD) 的盛行率不断上升，从而对标靶治疗的需求增加。随着介入和设备技术的进步，人们已经看到了向血管成形术和支架置入术等微创手术的重大转变。

预计这一趋势将继续增强，并为医疗设备製造商创新新产品创造重大机会。例如，2024年11月，飞利浦在美国招募了首批用于治疗週边动脉疾病 (PAD) 的新型整合设备临床试验患者。这种创新设备将雷射切除术和血管内碎石术结合到一个程序中，简化了工作流程，同时降低了风险并改善了患者的治疗效果。

週边血管介入市场的地理展望：

  • 北美预计将占据主要市场占有率：週边血管介入市场分为北美、南美、欧洲、中东和非洲、亚太地区。由于对可再生能源解决方案的强劲需求和政府促进永续性的奖励，北美预计将主导这一市场。美国市场尤其强劲，因为不断上升的肥胖率鼓励更多的人成为健身房会员并过上更健康的生活。

北美先进的医疗保健基础设施支援快速采用新的血管技术和治疗方法。此外，在美国等已开发国家，先进医疗服务的优惠报销政策增加了人们获得医疗服务的机会。週边动脉疾病 (PAD) 和深层静脉栓塞症形成病例的增加也推动了对週边血管介入设备的需求。区域参与者正在投资週边血管介入设备的技术创新，促进整体市场的成长。例如，2023年7月，Endologix宣布其DETOUR系统已成功用于第一位接受经皮硬膜动脉搭桥术（PTAB）的患者。这种创新方法允许医生使用通过股静脉的支架来绕过股浅动脉的病变。

为什么要购买这份报告？

  • 深刻分析：获得深入的市场洞察，涵盖主要和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 细分和区域分析，包括收益成长和预测国家
  • 公司概况（策略、产品、财务、主要发展等）

週边血管介入市场细分如下：

依产品类型

  • 支架
  • 气球
  • 动脉粥状硬化斑块切除术系统
  • 导管
  • 週边配件
  • 导管导引线
  • 其他的

按应用

  • 周边动脉疾病
  • 深层静脉栓塞症（DVT）
  • 动脉瘤
  • 静脉疾病
  • 肺动脉栓塞（PE）
  • 其他的

按最终用户

  • 医院
  • 门诊手术中心
  • 其他的

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 其他的
  • 中东和非洲
  • 沙乌地阿拉伯
  • UAE
  • 其他的
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 印尼
  • 泰国
  • 台湾
  • 其他的

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 政府监管
  • 专利和正在进行的研究
  • 临床试验和阶段分析
  • 盛行率和发病率分析

第五章週边血管介入市场（依产品类型）

  • 介绍
  • 支架
  • 气球
  • 动脉粥状硬化斑块切除术系统
  • 导管
  • 週边配件
    • 导管导引线
  • 其他的

第六章 週边血管介入市场（依应用）

  • 介绍
  • 周边动脉疾病
  • 深层静脉栓塞症（DVT）
  • 动脉瘤
  • 静脉疾病
  • 肺动脉栓塞（PE）
  • 其他的

第 7 章 週边血管介入市场（依最终使用者）

  • 介绍
  • 医院
  • 门诊手术中心
  • 其他的

8. 週边血管介入市场（按地区）

  • 介绍
  • 北美洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 南美洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 欧洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 中东和非洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 亚太地区
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 合併、收购、协议和合作
  • 供应商矩阵

第十章 公司简介

  • Boston Scientific Corporation
  • Abbott Laboratories
  • BD（Becton, Dickinson and Company）
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • BIOTRONIK
  • Medtronic
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Cook Medical
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems
  • Philips
  • TE Connectivity
  • AngioDynamics
简介目录
Product Code: KSI061617250

The peripheral vascular intervention market is estimated to grow at a CAGR of 5.74% to reach a market size of US$18.198 billion in 2030 from US$13.765 billion in 2025.

Peripheral vascular interventions (PVI) are minimally invasive treatments that utilize flexible devices to access blood vessels outside the heart. These procedures can open blocked vessels, remove blood clots, and manage high blood pressure. PVI represents a cutting-edge approach that minimizes the need for large incisions, resulting in faster recovery times, reduced pain, lower complication risks, and shorter hospital stays. Interventional cardiologists leverage these advanced treatment devices to enhance patient outcomes.The peripheral vascular intervention market is expanding primarily due to the rising prevalence of peripheral artery disease (PAD) and advancements in technology. This growth is further supported by an increasing preference for minimally invasive procedures, an aging population, and higher healthcare spending. PAD restricts blood flow to the limbs and is becoming more common due to factors like diabetes, obesity, and smoking. Innovative devices such as drug-eluting stents, atherectomy devices, and embolization particles have improved performance and patient outcomes. Additionally, the growing elderly population and increased healthcare expenditure are directly contributing to the demand for these treatments.

Drivers of the Peripheral Vascular Intervention Market:

  • Rising Prevalence of Peripheral Arterial Disease (PAD): The increasing incidence of PAD is a significant factor driving the growth of the peripheral vascular intervention market. PAD occurs when arteries supplying blood to the limbs become narrowed or blocked by plaque, leading to symptoms such as leg pain and poor wound healing. The prevalence of PAD is rising due to unhealthy lifestyles, which in turn increases the demand for targeted treatments. There is a notable shift toward minimally invasive therapies like angioplasty and stenting, along with advancements in interventional techniques and device technologies.

This trend is expected to continue gaining momentum, creating substantial opportunities for medical device manufacturers to innovate new products. For instance, in November 2024, Philips registered its first patient in the U.S. for a clinical trial involving a novel integrated device designed to treat PAD. This innovative device combines laser atherectomy with intravascular lithotripsy into a single procedure, streamlining workflow while reducing risks and improving patient outcomes.

Geographical Outlook of the Peripheral Vascular Intervention Market:

  • North America Anticipated to Hold Significant Market Share: The peripheral vascular intervention market is segmented into North America, South America, Europe, the Middle East & Africa, and Asia-Pacific regions. North America is expected to dominate this market due to a strong demand for renewable energy solutions and government incentives promoting sustainability. The U.S. market is particularly robust due to rising obesity rates that encourage gym memberships and healthier lifestyles.

The advanced healthcare infrastructure in North America supports rapid adoption of new vascular technologies and treatments. Furthermore, favorable reimbursement policies for advanced healthcare services enhance access in developed economies like the United States. Growing cases of PAD and deep vein thrombosis are also driving demand for peripheral vascular intervention devices.Regional players are investing in innovation within peripheral vascular intervention devices, contributing to overall market growth. For example, in July 2023, Endologix announced that its DETOUR system successfully completed its first patients undergoing Percutaneous Transmural Arterial Bypass (PTAB). This innovative approach allows doctors to bypass lesions in the superficial femoral artery using stents routed through the femoral vein-particularly beneficial for long lesions or patients unsuitable for traditional surgical bypass.In summary, the peripheral vascular intervention market is poised for significant growth driven by rising prevalence of PAD requiring advanced treatment options, increasing adoption of minimally invasive procedures, technological advancements enhancing device performance, and substantial geographical developments-especially within North America-that support this expanding market landscape.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Peripheral Vascular Intervention Market has been segmented as following:

By Product Type

  • Stents
  • Balloons
  • Atherectomy System
  • Catheters
  • Peripheral Accessories
  • Guidewires
  • Others

By Application

  • Peripheral Artery Disease
  • Deep Vein Thrombosis (DVT)
  • Aneurysms
  • Venous Disease
  • Pulmonary Embolism (PE)
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Government Agencies Regulations
  • 4.6. Patents and Ongoing Research
  • 4.7. Clinical Trials and Phase Analysis
  • 4.8. Prevalence and Incidence Rate Analysis

5. PERIPHERAL VASCULAR INTERVENTION MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Stents
  • 5.3. Balloons
  • 5.4. Atherectomy System
  • 5.5. Catheters
  • 5.6. Peripheral Accessories
    • 5.6.1. Guidewires
  • 5.7. Others

6. PERIPHERAL VASCULAR INTERVENTION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Peripheral Artery Disease
  • 6.3. Deep Vein Thrombosis (DVT)
  • 6.4. Aneurysms
  • 6.5. Venous Disease
  • 6.6. Pulmonary Embolism (PE)
  • 6.7. Others

7. PERIPHERAL VASCULAR INTERVENTION MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Others

8. PERIPHERAL VASCULAR INTERVENTION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.3. Vendor Matrix

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. Abbott Laboratories
  • 10.3. BD (Becton, Dickinson and Company)
  • 10.4. Zylox-Tonbridge Medical Technology Co., Ltd.
  • 10.5. BIOTRONIK
  • 10.6. Medtronic
  • 10.7. Terumo Corporation
  • 10.8. B. Braun Melsungen AG
  • 10.9. Cook Medical
  • 10.10. Meril Life Sciences Pvt. Ltd.
  • 10.11. Merit Medical Systems
  • 10.12. Philips
  • 10.13. TE Connectivity
  • 10.14. AngioDynamics